| | Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 4, 2022 /PRNewswire/ -- SenesTech Inc. (NASDAQ: SNES) will report financial results for its second quarter 2022, ended June 30, 2022, after the market close on Thursday, August 11, 2022. The Company has scheduled a conference call that same day, Thursday, August 11, 2022, at 5:00 pm ET, to review the results. Second Quarter 2022 Conference Call Details Date and Time: Thursday, August 11, 2022, at 5:00 pm ET Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407. Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/. Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 4931404. A webcast replay will be available in the Investor Relations section of the Company’s website at http://senestech.investorroom.com/ for 90 days. About SenesTech
We are “The Pest Control Difference” for the 21st century. We are rodent fertility control specialists fueled by our passion to create a healthy environment by virtually eliminating rodent pest populations. We keep an inescapable truth in mind: 2 rats and their descendants can be responsible for the birth of up to 15,000 pups in a year. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses, and happy households – with a product that was designed to be effective and sustainable without killing rats. At SenesTech, we don’t just eliminate rats. We make a better world. For more information visit https://senestech.com/ and https://contrapeststore.com. Safe Harbor Statement
The foregoing paragraphs contain forward-looking statements that involve estimates, assumptions, risks and uncertainties. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. “Forward-looking statements” may be preceded by words such as “may,” “future,” “plan” or “planned,” “will,” “should,” “expected,” “anticipates,” “continue,” “eventually,” “believes,” or “projected.” Forward-looking statements include statements concerning the potential impact and effects of the COVID-19 pandemic on the Company’s business, results of operations and financial performance; any measures the Company has and may take in response to COVID-19 and any expectations the Company may have with respect thereto; the Company’s strategy and target marketing and markets; continuing the Company’s vision; expected benefits of the Company’s initiatives and continuation of those initiatives; deployment of the Company’s product; the continuation or expansion of the use of ContraPest; demand for ContraPest; the Company’s expectation regarding costs, expenses and cash and continuing its cost improvement plan; future financial results; and the Company’s execution of its strategic business plan.  View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-second-quarter-2022-financial-results-on-thursday-august-11-2022-301599770.html
SOURCE SenesTech, Inc. | |
